First Stage of the Creatinine Standardization Program in the Province of Chaco. Clinical Laboratories Technologies and Procedures Survey

  • Gustavo A. Velasco Hospital Dr. Julio C. Perrando, Ministerio de Salud Pública, Resistencia, Chaco
  • María Eugenia Bianchi Cátedra de Fisiología, Facultad de Medicina, Universidad Nacional del Nordeste, Corrientes
  • Ana María Cusumano Sección Nefrología, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (CEMIC), Buenos Aires
  • Ana María Susan Tauguinas Fundación Renal del Nordeste Argentino, Chaco
  • Daniel Mazziotta Laboratorio de Referencia y Estandarización en Química Clínica (LARESBIC), Fundación Bioquímica Argentina, La Plata, Buenos Aires
Keywords: standardization program plasma, creatinine, clinical laboratories, Plasmatic Creatinine Standardization Program

Abstract

Introduction: The Ministry of Public Health, la Fundación Renal del Nordeste Argentino (Renal Foundation of the Argentinean Northeast), el Colegio Bioquímico (Biochemical School), all the institutions of the Province of Chaco, and La Fundación Bioquímica Argentina (Argentinean Biochemical Foundation) began the development of a Plasmatic Creatinine Standardization Program (PCrSP). Objective: The objective is to present the results of the survey conducted in the Clinical Laboratories (CL). Methods: A survey was performed in 100% (n= 39) of the CL participating in the program; 22 (56%) of them belong to the public sector and were selected by complexity, monthly rate of creatinine determinations, and proximity to vulnerable populations, and 17 (44%) of them are private CL that agreed to participate. Results: The results were as follows: 1) Technology: automatic (44.8%), semi-automatic (37.9%), manual (17.2%); 2) Method: 5 (13.9%) used endpoint and 31 (86.1%) used kinetic method; 3 laboratories did not provide a response; 3) Calibrators: 18 (36.7%) used serum matrix, and 7 (17.9%) aqueous patterns, and no data was obtained from 14 (35.9%) labs; 4) The Homogeneous systems were verified for 5 (13.2%) labs, and for 33 (86.8%) of them systems were heterogeneous; 5) Temperature: 16 (43.2%) reacted at 25 ºC, and 19 (51.4%) at 37 ºC; 6) Internal Quality Controls (IQC) and External Quality Controls (EQC): 15 (48.3%) performed both, 6 (19.4%) performed neither, 10 (32.3%) performed either of them (IQC or EQC), where 51.7% of the participating laboratories had partial or absent controls. Conclusions: Considering the heterogeneity observed in both the tools and the determination conditions, new operating lines for standardization were defined.

References

Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258-70.

Chronic Kidney Disease Prognosis Consortium, Matsushita K, Van der Velde M, Astor BC, Woodward M, Levey AS, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073-81.

Hallan SI, Orth SR. The KDOQI 2002 classification of chronic kidney disease: for whom the bell tolls. Nephrol Dial Transplant. 2010;25(9):2832-6.

Martins D, Tareen N, Zadshir A, Pan D, Vargas R, Nissenson A, et al. The association of poverty with the prevalence of albuminuria: data from the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2006;47(6):965-71.

Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med. 2006;354(10):997-9.

James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet. 2010;375(9722):1296-309.

Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine [abstract]. J Am Soc Nephrol. 2000;11:155A.

Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247-54.

Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek J, et al. Expressing the MDRD study equation for estimating GFR with IDMS traceable (Gold Standard) serum creatinine values [abstract]. J Am Soc Nephrol. 2005;16:A69.

National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-266.

Hallan SI, Ritz E, Lydersen S, Romundstad S, Kvenild K, Orth SR. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol. 2009;20(5):1069-77.

Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA. 2010;303(5):423-9.

Chile. Ministerio de Salud. Guía Clínica Prevención de Enfermedad Renal Crónica [Internet]. Santiago, 2010. Disponible en: http://web.minsal.cl/portal/url/item/955578f79a1bef2ae04001011f01678a.pdf [consulta: 19/08/2012].

Taal MW, Tomson C. Clinical Practice Guidelines. Module 1: Chronic Kidney Disease [Internet]. 2nd ed. UK Renal Association, 2007. Disponible en: http://www.renal.org/docs/default-source/guidelines-resources/1_-_CKD_-_Current_version.pdf [consulta: 19/08/2012].

Kagoma YK, Weir MA, Iansavichus AV, Hemmelgarn BR, Akbari A, Patel UD, et al. Impact of estimated GFR reporting on patients, clinicians, and health-care systems: a systematic review. Am J Kidney Dis. 2011;57(4):592-601.

Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002;39(5):920-9.

Miller WG, Myers GL, Ashwood ER, Killeen AA, Wang E, Thienpont LM, et al. Creatinine measurement: state of the art in accuracy and interlaboratory harmonization. Arch Pathol Lab Med. 2005;129(3):297-304.

Hallan S, Asberg A, Lindberg M, Johnsen H. Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis. 2004;44(1):84-93.

Sociedad Argentina de Nefrología, Asociación Bioquímica Argentina, Fundación Bioquímica Argentina. Documento multidisciplinario para la detección precoz de Enfermedad Renal Crónica [Internet]. Disponible en: http://www.fba.org.ar/institucional/novedades/2009-07-002-convenio.html [consulta: 19/08/2012].

Argentina. Instituto Nacional de Estadísticas y Censos. [Distribución de los laboratorios participantes por Departamento de la Provincia del Chaco, densidad poblacional (habitantes/km2) y población cubierta]. Disponible en: http://www.indec.gob.ar [consulta: 19/08/2012].

Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem. 2006;52(1):5-18.

Inserra F, Cornelio C, Daverio S, Diehl, S, Samarelli N, Díaz A. Estratificación de la función renal de la población con cobertura social en la ciudad de Buenos Aires [abstract]. Nefrol Argent. 2003;1(1):50.

Alles A, González M, González S, Rodríguez P, Torales S. Aplicación sistemática de MDRD: análisis de prevalencia de enfermedad renal crónica y costo efectividad [abstract]. Nefrol Argent. 2011;9(2):98-9.

Alles A, Fraga A, García R, Gómez A, Greloni G, Inserra F, et al. Detección precoz de enfermedad renal crónica. Acta Bioquím Clín Latinoam. 2010;44(3):377-84.

Burtis CA, Ashwood ER, Bruns DE. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 5th ed. St. Louis: Elsevier/Saunders, 2012. xviii, 2238 p.

Published
2017-09-05
How to Cite
1.
Velasco GA, Bianchi ME, Cusumano AM, Tauguinas AMS, Mazziotta D. First Stage of the Creatinine Standardization Program in the Province of Chaco. Clinical Laboratories Technologies and Procedures Survey. Rev Nefrol Dial Traspl. [Internet]. 2017Sep.5 [cited 2024Dec.28];33(1):25-3. Available from: http://vps-1689312-x.dattaweb.com/index.php/rndt/article/view/175
Section
Original Article